Last reviewed · How we verify

NCT04325971: EyeProxy

Study of Eye Movements as Markers of the Physiological, Cerebral and Cognitive State of Healthy Subjects

Completed NA Last updated 9 May 2022
What this trial tests

NA trial testing Neuroimaging in Healthy in 45 participants. Completed in 22 July 2021.

Timeline
16 September 2020
Primary endpoint
22 July 2021
22 July 2021

Quick facts

Lead sponsorUniversity Hospital, Grenoble
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposebasic science
Enrollment45
Start date16 September 2020
Primary completion22 July 2021
Estimated completion22 July 2021
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Grenoble

Who can join

Adults 18 to 40, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is the multimodal exploration via eyetracking, MRI and EEG data of ocular movements and the corresponding brain activation during ecologic visual stimulation in the healthy population.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Neuroimaging

Trials testing the same drug.

Other recruiting trials for Healthy

Currently open trials in the same condition.

Other University Hospital, Grenoble trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04325971.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing